mouse hepatoma cell line hepa1 6 (Procell Inc)
Structured Review

Mouse Hepatoma Cell Line Hepa1 6, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse hepatoma cell line hepa1 6/product/Procell Inc
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "HMBOX1 inhibits hepatocellular carcinoma progression via PTPN1 mediated AKT1 phosphorylation"
Article Title: HMBOX1 inhibits hepatocellular carcinoma progression via PTPN1 mediated AKT1 phosphorylation
Journal: Oncology Reports
doi: 10.3892/or.2026.9052
Figure Legend Snippet: Inhibitory effect of HMBOX1 on HCC is dependent on the blocking of AKT1 phosphorylation. (A and B) The difference in protein expression between HMBOX1-overexpressing cells and control cells was analyzed through proteomics, and the results are shown in the form of volcano map (A) and heat map (B) respectively. (C and D) HCC cells were transfected with lentiviral vector to overexpress HMBOX1 and then treated with 4 µM SC79 for different times. The expression levels of AKT1 and p-AKT1 (Ser473) were determined through western blotting in Hepa1-6 and Huh-7 cells from different groups. (E-H) The proliferation and cell migration ability of Hepa1-6 and Huh-7 cells from each group were analyzed using a Cell Counting Kit-8 assay (E and F) and wound healing assay (G and H) (I) The proliferation ability of Huh-7 cells from different groups was assessed through the colony formation assay. *P<0.05 and **P<0.01. HMBOX1, homeobox containing 1; HCC, hepatocellular carcinoma.
Techniques Used: Blocking Assay, Phospho-proteomics, Expressing, Control, Transfection, Plasmid Preparation, Western Blot, Migration, Cell Counting, Wound Healing Assay, Colony Assay
Figure Legend Snippet: Overexpression of HMBOX1 can inhibit tumor growth in hepatocellular carcinoma bearing mice. A total of 5×10 6 Hepa1-6 cells overexpressing HMBOX1 (Over-HMBOX1) or transfected with empty vector (Vector) were subcutaneously injected into the right subaxillary region of C57BL/6 mice (n=6). (A) Tumor growth curves were measured every three days. (B) Representative images and the tumor weight of the subcutaneous tumors from each group. (C) The expression levels of indicated molecules were determined through western blotting in different tumor tissues. **P<0.01. HMBOX1, homeobox containing 1; PTPN1, protein tyrosine phosphatase non-receptor type 1; p-, phosphorylated.
Techniques Used: Over Expression, Transfection, Plasmid Preparation, Injection, Expressing, Western Blot
![Glucose metabolism of HCC cells affects their ability of activating HSC. (A) The human HCC scRNA‐seq ( n = 29 patients, GSE151530 ) was analysed to demonstrate the correlation between the glucose metabolism (reactome‐glucose metabolism) in HCC cells and the ACTA2 expression in HSCs. (B) LX‐2 cells were cultured in the presence of conditional medium from Huh7 cells or HK1‐overexpressing Huh7 cells for 1 week. Cell morphology and α‐SMA expression of LX‐2 cells were indicated. (C) The supernatants of the Huh7 cells treated with or without 2‐DG (5 mM) were collected to incubate LX‐2 cells for 1 week. α‐SMA expression of LX‐2 cells was indicated. (D) Primary HSCs from C57BL/6 mice were incubated with the medium <t>of</t> <t>Hepa1‐6</t> cells or HK1‐overexpressing Hepa1‐6 cells, α‐SMA expression of primary HSCs was indicated. (E) Hepa1‐6 cells were treated with or without 2‐DG (5 mM) for 24 h, and then the corresponding supernatants were collected to incubate primary HSCs. (F, G) LX‐2 cells were initially treated with TGF‐β1 (2 ng/mL) for 48 h, and then lEVs were collected. Nanoflow cytometry was applied to characterise the size profile (F) and number (G) of isolated lEVs ( n = 3 independent experiments). (H) Transmission electron microscopy was applied to visualise the isolated lEVs. (I) HK1 protein was detected in lEVs‐derived from indicated LX‐2 cells. Flotillin‐2 was used as a loading control for lEVs. WCL, whole cell lysates. (J) lEVs derived from activated control and HK1‐knockdown LX‐2 cells were collected to incubate Huh7 cells. HK1 protein level in Huh7 cells was detected. (K) As the diagram shown, LX‐2 cells were incubated with the corresponding supernatants of indicated Huh7 cells, then α‐SMA expression of LX‐2 cells was indicated. (L) LX‐2 cells were cultured with normal DMEM or medium of Huh7 cells or HK1‐overexpressing Huh7 cells for 1 week, then refresh normal DMEM for culturing another 48 h to collect their lEVs. (M) The correlation between HK1 and ACTA2 expression in HSCs were analysed using the human HCC scRNA‐seq data ( GSE151530 ). (N) The expression levels of ACTA2 in HSCs were analysed using human HCC [ n (low) = 14 tissues, n (high) = 15 tissues, GSE151530 ] and normal liver [ n (low) = 4 tissues, n (high) = 4 tissues, GSE158723 ] scRNA‐seq data. Statistical data are presented as mean ± s.e.m. of indicated samples. Statistical analyses were determined by Pearson correlation (A, M), unpaired two‐tailed Student's t test (G) and Wilcoxon test (N). All western blots were repeated at least twice, and one of them is shown. α‐SMA, alpha smooth muscle actin; 2‐DG, 2‐deoxy‐D‐glucose; DMEM, Dulbecco's modified Eagle's medium; HCC, hepatocellular carcinoma; HK1, hexokinase 1; HSC, hepatic stellate cell; lEV, large extracellular vesicle; TGF‐β1, transforming growth factor‐β1.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_4909/pmc12974909/pmc12974909__JEV2-15-e70255-g002.jpg)
